For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
According to our LPI (LP Information) latest study, the global Oral Proteins and Peptides market size was valued at US$ 2449 million in 2023. With growing demand in downstream market, the Oral Proteins and Peptides is forecast to a readjusted size of US$ 6769.8 million by 2030 with a CAGR of 15.6% during review period.
The research report highlights the growth potential of the global Oral Proteins and Peptides market. Oral Proteins and Peptides are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Oral Proteins and Peptides. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Oral Proteins and Peptides market.
Polypeptide and protein drugs refer to the biological drugs of polypeptide and protein substances used for prevention,treatment and diagnosis.Polypeptide is a compound formed by linking ?-amino acids together with a peptide chain,and it is also an intermediate product of proteolysis.N polypeptide chains are entangled in a certain spatial structure to form a protein.The hydrolysis of macromolecular proteins produces polypeptides.Such drugs are biochemical preparations and have relatively strict requirements on storage and transportation environment.The Oral Proteins and Peptides industry can be broken down into several segments, Linaclotide, Insulin, Plecanatide, Cyclosporine, Octreotide, etc.Across the world, the major players cover Ironwood & Allergan (AbbVie), Novo Nordisk, Synergy Pharmaceuticals (Salix), Novartis, Chiasma (Amryt Pharma), etc.
Ironwood & Allergan is one of the most important global manufacturers of oral proteins and peptides, other key manufacturers include Novo Nordisk. North America is the largest market, occupied for over 60%. In terms of type, insulin is the largest segment, with a share of over 60%. And in terms of application, gastric & digestive disorders and bone diseases segment holds the most share.
Key Features:
The report on Oral Proteins and Peptides market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Oral Proteins and Peptides market. It may include historical data, market Segmentation by Type (e.g., Linaclotide, Insulin), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Oral Proteins and Peptides market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Oral Proteins and Peptides market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Oral Proteins and Peptides industry. This include advancements in Oral Proteins and Peptides technology, Oral Proteins and Peptides new entrants, Oral Proteins and Peptides new investment, and other innovations that are shaping the future of Oral Proteins and Peptides.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Oral Proteins and Peptides market. It includes factors influencing customer ' purchasing decisions, preferences for Oral Proteins and Peptides product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Oral Proteins and Peptides market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Oral Proteins and Peptides market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Oral Proteins and Peptides market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Oral Proteins and Peptides industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Oral Proteins and Peptides market.
Market Segmentation:
Oral Proteins and Peptides market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
- Linaclotide
- Insulin
- Plecanatide
- Cyclosporine
- Octreotide
Segmentation by application
- Gastric & Digestive Disorders
- Bone Diseases
- Diabetes
- Hormonal Disorders
This report also splits the market by region:
- Americas
- - United States
- - Canada
- - Mexico
- - Brazil
- APAC
- - China
- - Japan
- - Korea
- - Southeast Asia
- - India
- - Australia
- Europe
- - Germany
- - France
- - UK
- - Italy
- - Russia
- Middle East & Africa
- - Egypt
- - South Africa
- - Israel
- - Turkey
- - GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
- Ironwood & Allergan
- Novo Nordisk
- Synergy Pharmaceuticals ?Salix?
- Novartis
- Chiasma (Amryt Pharma)
Key Questions Addressed in this Report
What is the 10-year outlook for the global Oral Proteins and Peptides market?
What factors are driving Oral Proteins and Peptides market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Oral Proteins and Peptides market opportunities vary by end market size?
How does Oral Proteins and Peptides break out type, application?